Pharmaceutical combination of pazopanib and topotecan to treat neuroblastoma, osteosarcoma, and rhabdomyosarcoma in a human
    1.
    发明授权
    Pharmaceutical combination of pazopanib and topotecan to treat neuroblastoma, osteosarcoma, and rhabdomyosarcoma in a human 失效
    帕可帕尼与托泊替康的药物联合治疗人类的神经母细胞瘤,骨肉瘤和横纹肌肉瘤

    公开(公告)号:US08709420B2

    公开(公告)日:2014-04-29

    申请号:US13990515

    申请日:2011-11-23

    CPC classification number: A61K31/506 A61K31/4375 A61K31/4745 A61K2300/00

    Abstract: The present invention relates to methods of treating neuroblastoma, osteosarcoma, and rhabdomyosarcoma in a human and to pharmaceutical combinations useful in such treatment. In particular, the method relates to a neuroblastoma treatment method that includes administering 5-[[4-[(2,3-dimethyl-2H-indazol-6-yl)methylamino]-2-pyrimidinyl]amino]-2-methylbenzenesulfonamide, or a pharmaceutically acceptable salt thereof, and (S)-10-[(dimethylamino)methyl]-4-ethyl-4,9-dihydroxy-1H-pyrano[3′,4′:6,7]indolizino[1,2-b]quinoline-3,14-(4H,12H)-dione, or a pharmaceutically acceptable salt thereof, to a human in need thereof.

    Abstract translation: 本发明涉及治疗人类的神经母细胞瘤,骨肉瘤和横纹肌肉瘤的方法以及用于这种治疗的药物组合。 特别地,该方法涉及神经母细胞瘤治疗方法,其包括施用5 - [[4 - [(2,3-二甲基-2H-吲唑-6-基)甲基氨基] -2-嘧啶基]氨基] -2-甲基苯磺酰胺, 或其药学上可接受的盐,和(S)-10 - [(二甲基氨基)甲基] -4-乙基-4,9-二羟基-1H-吡喃并[3',4':6,7]吲哚并[1,2 b]喹啉-3,14-(4H,12H) - 二酮或其药学上可接受的盐。

    Combination
    2.
    发明申请
    Combination 失效
    组合

    公开(公告)号:US20130252991A1

    公开(公告)日:2013-09-26

    申请号:US13990515

    申请日:2011-11-23

    CPC classification number: A61K31/506 A61K31/4375 A61K31/4745 A61K2300/00

    Abstract: The present invention relates to methods of treating neuroblastoma, osteosarcoma, and rhabdomyosarcoma in a human and to pharmaceutical combinations useful in such treatment. In particular, the method relates to a neuroblastoma treatment method that includes administering 5-[[4-[(2,3-dimethyl-2H-indazol-6-yl)methylamino]-2-pyrimidinyl]amino]-2-methylbenzenesulfonamide, or a pharmaceutically acceptable salt thereof, and (S)-10-[(dimethylamino)methyl]-4-ethyl-4,9-dihydroxy-1H-pyrano[3′,4′:6,7]indolizino[1,2-b]quinoline-3,14-(4H,12H)-dione, or a pharmaceutically acceptable salt thereof, to a human in need thereof.

    Abstract translation: 本发明涉及治疗人类的神经母细胞瘤,骨肉瘤和横纹肌肉瘤的方法以及用于这种治疗的药物组合。 特别地,该方法涉及神经母细胞瘤治疗方法,其包括施用5 - [[4 - [(2,3-二甲基-2H-吲唑-6-基)甲基氨基] -2-嘧啶基]氨基] -2-甲基苯磺酰胺, 或其药学上可接受的盐,和(S)-10 - [(二甲基氨基)甲基] -4-乙基-4,9-二羟基-1H-吡喃并[3',4':6,7]吲哚并[1,2 b]喹啉-3,14-(4H,12H) - 二酮或其药学上可接受的盐。

Patent Agency Ranking